Deficit Syndromes in Schizophrenia

Deficit syndromes in schizophrenia designate a subgroup of patients who experience primary and enduring negative symptoms—such as social withdrawal, diminished emotional expression and low motivation—that are intrinsic to the disorder rather than secondary to medication, depression or psychotic relapse. This phenotype has been delineated as a distinct nosological entity, often exhibiting poorer functional outcome, greater cognitive impairment and reduced quality of life compared with non-deficit presentations. Neuroimaging studies reveal that individuals with deficit features tend to have more pronounced reductions in cortical thickness, particularly within fronto-parietal networks, and white matter abnormalities in tracts mediating motivational circuits. Neurobiological investigations implicate alterations in dopaminergic and glutamatergic transmission, as well as distinctive inflammatory and genetic signatures. Clinically, the recognition of deficit syndromes facilitates stratification in trials of psychosocial interventions and guides the development of targeted pharmacological and neuromodulatory therapies. Acknowledging this subgroup’s global burden emphasises the need for early identification, personalised care pathways and biomarker-driven research to mitigate long-term disability and societal cost.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Deficit Syndromes in Schizophrenia publication trend

The graph below shows the total number of articles in deficit syndromes in schizophrenia across all publications each year (not limited to Nature Index journals).

Technical terms

Negative symptoms: Core deficits in motivation, social engagement and affective expression that are primary and persistent in a subtype of schizophrenia.

Cortical thickness: A measure of grey matter integrity in the brain’s cortex, often derived from magnetic resonance imaging to assess neuroanatomical alterations.

Functional connectivity: Statistical associations between activity in distinct brain regions, typically measured with resting-state or task-based functional MRI to infer network integrity.

Inflammatory cytokines: Signalling proteins released by immune cells that can influence neural function and have been linked to psychiatric symptom profiles.

References

1. Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses. Molecular Psychiatry (2023).
2. Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study. Journal of Clinical Medicine (2021).
3. Convergent and divergent genes expression profiles associated with brain-wide functional connectome dysfunction in deficit and non-deficit schizophrenia. Translational Psychiatry (2024).
4. Differences in inflammatory marker profiles and cognitive functioning between deficit and nondeficit schizophrenia. Frontiers in Immunology (2022).